Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 12

1.

Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial.

Ehlken N, Lichtblau M, Klose H, Weidenhammer J, Fischer C, Nechwatal R, Uiker S, Halank M, Olsson K, Seeger W, Gall H, Rosenkranz S, Wilkens H, Mertens D, Seyfarth HJ, Opitz C, Ulrich S, Egenlauf B, Grünig E.

Eur Heart J. 2016 Jan 1;37(1):35-44. doi: 10.1093/eurheartj/ehv337. Epub 2015 Jul 31.

2.

Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary disease.

Ghofrani HA, Staehler G, Grünig E, Halank M, Mitrovic V, Unger S, Mueck W, Frey R, Grimminger F, Schermuly RT, Behr J.

Pulm Circ. 2015 Jun;5(2):296-304. doi: 10.1086/680214.

3.

Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.

Thomas K, Schrötter H, Halank M, Ziemssen T.

BMC Neurol. 2014 Jun 7;14:126. doi: 10.1186/1471-2377-14-126.

4.

Everolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial.

Seyfarth HJ, Hammerschmidt S, Halank M, Neuhaus P, Wirtz HR.

Pulm Circ. 2013 Sep;3(3):632-8. doi: 10.1086/674311. Epub 2013 Nov 19.

5.

Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Harzheim D, Klose H, Pinado FP, Ehlken N, Nagel C, Fischer C, Ghofrani A, Rosenkranz S, Seyfarth HJ, Halank M, Mayer E, Grünig E, Guth S.

Respir Res. 2013 Oct 9;14:104. doi: 10.1186/1465-9921-14-104.

6.

Pulmonary hypertension in patients with idiopathic pulmonary fibrosis - the predictive value of exercise capacity and gas exchange efficiency.

Gläser S, Obst A, Koch B, Henkel B, Grieger A, Felix SB, Halank M, Bruch L, Bollmann T, Warnke C, Schäper C, Ewert R.

PLoS One. 2013 Jun 20;8(6):e65643. doi: 10.1371/journal.pone.0065643. Print 2013.

7.

Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension.

Nagel C, Prange F, Guth S, Herb J, Ehlken N, Fischer C, Reichenberger F, Rosenkranz S, Seyfarth HJ, Mayer E, Halank M, Grünig E.

PLoS One. 2012;7(7):e41603. doi: 10.1371/journal.pone.0041603. Epub 2012 Jul 25.

8.

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases.

Grünig E, Maier F, Ehlken N, Fischer C, Lichtblau M, Blank N, Fiehn C, Stöckl F, Prange F, Staehler G, Reichenberger F, Tiede H, Halank M, Seyfarth HJ, Wagner S, Nagel C.

Arthritis Res Ther. 2012 Jun 18;14(3):R148. doi: 10.1186/ar3883.

9.

Prolactin and its 16-kDa N-terminal fragment: are higher in patients with precapillary pulmonary hypertension than in a healthy control group.

Hönicke U, Albrecht S, Schrötter H, Krug S, Kolditz M, Kuhlisch E, Höffken G, Halank M.

Tex Heart Inst J. 2012;39(1):44-50.

10.

Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy.

Knudsen L, Schurawlew A, Nickel N, Tiede H, Ghofrani HA, Wilkens H, Ewert R, Halank M, Klose H, Bäzner C, Behr J, Hoeper MM.

BMC Pulm Med. 2011 Dec 1;11:56. doi: 10.1186/1471-2466-11-56.

11.

Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension.

Koehler R, Grünig E, Pauciulo MW, Hoeper MM, Olschewski H, Wilkens H, Halank M, Winkler J, Ewert R, Bremer H, Kreuscher S, Janssen B, Nichols WC.

J Med Genet. 2004 Dec;41(12):e127. No abstract available.

12.

Long term survival in primary pulmonary hypertension.

Halank M, Marx C, Hoeffken G.

Heart. 2004 Jul;90(7):e40.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk